Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension. Twenty-...
Gespeichert in:
| Veröffentlicht in: | Circulation. Cardiovascular interventions 2012-12, Vol.5 (6), p.756-762 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 762 |
|---|---|
| container_issue | 6 |
| container_start_page | 756 |
| container_title | Circulation. Cardiovascular interventions |
| container_volume | 5 |
| creator | KATAOKA, Masaharu INAMI, Takumi SATOH, Toru HAYASHIDA, Kentaro SHIMURA, Nobuhiko ISHIGURO, Haruhisa ABE, Takayuki TAMURA, Yuichi ANDO, Motomi FUKUDA, Keiichi YOSHINO, Hideaki |
| description | Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension.
Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P |
| doi_str_mv | 10.1161/circinterventions.112.971390 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273270534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1273270534</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-8ef0c1654a66529f44ebf7fc85ca3ba5b7444046bdb3a4be61a600b29df7b93b3</originalsourceid><addsrcrecordid>eNpFkF9LHDEUxYO0qLV-BZkHC76szb_JzEBfZNjWBVnFTn0dkuyNRjLJNskU9ts3Zbf6EG5y-N17Tw5ClwRfEyLIV22jtj5D_AM-2-BTkel11xDW4SN0SjpOFo1g9MPbneMT9CmlV4yLLOgxOqGMMEpZc4riA0Q9Z-khzKkaovTJzZP10lUPs5uCl3FX3fhnG7ZOpryrTIhVfoGCgsxTsVAFU_UvMXirq6HUSQUox5Xn-4Tb3RZiBp-K4c_oo5EuwfmhnqFf35dDf7u4u_-x6m_uFrpmNC9aMFgTUXMpRE07wzko0xjd1loyJWvVcM4xF2qjmOQKBJECY0W7jWlUxxQ7Q1f7udsYfs-Q8jjZpMG5_WdHQhtGG1wzXtBve1THkFIEM26jnYrxkeDxX-pjv3rsV-th-fi0XA-r-_XPItNxn3ppvzhsmtUEm7fm_zEX4MsBkElLZ0rM2qZ3TrSkbVnN_gK-n5Ls</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1273270534</pqid></control><display><type>article</type><title>Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension</title><source>MEDLINE</source><source>American Heart Association</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>KATAOKA, Masaharu ; INAMI, Takumi ; SATOH, Toru ; HAYASHIDA, Kentaro ; SHIMURA, Nobuhiko ; ISHIGURO, Haruhisa ; ABE, Takayuki ; TAMURA, Yuichi ; ANDO, Motomi ; FUKUDA, Keiichi ; YOSHINO, Hideaki</creator><creatorcontrib>KATAOKA, Masaharu ; INAMI, Takumi ; SATOH, Toru ; HAYASHIDA, Kentaro ; SHIMURA, Nobuhiko ; ISHIGURO, Haruhisa ; ABE, Takayuki ; TAMURA, Yuichi ; ANDO, Motomi ; FUKUDA, Keiichi ; YOSHINO, Hideaki</creatorcontrib><description>Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension.
Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P<0.01). Hemodynamic parameters also significantly improved (mean pulmonary arterial pressure, 45.3 ± 9.8 versus 31.8 ± 10.0 mm Hg; cardiac output, 3.6 ± 1.2 versus 4.6 ± 1.7 L/min, baseline versus follow-up, respectively; both P<0.01). Twenty-seven of 51 procedures in total (53%), and 19 of 28 first procedures (68%), had reperfusion pulmonary edema as the chief complication. Patients with severe clinical signs and/or severe hemodynamics at baseline had a high risk of reperfusion pulmonary edema.
PTPA improved subjective symptoms and objective variables, including pulmonary hemodynamics. PTPA may be a promising therapeutic strategy for the treatment of chronic thromboembolic pulmonary hypertension.
URL: http://www.umin.ac.jp. Unique identifier: UMIN000001572.</description><identifier>ISSN: 1941-7640</identifier><identifier>EISSN: 1941-7632</identifier><identifier>DOI: 10.1161/circinterventions.112.971390</identifier><identifier>PMID: 23132237</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Angioplasty, Balloon - adverse effects ; Angioplasty, Balloon - mortality ; Arterial Pressure ; Biological and medical sciences ; Biomarkers - blood ; Cardiovascular system ; Chronic Disease ; Diseases of the cardiovascular system ; Emergency and intensive care: renal failure. Dialysis management ; Familial Primary Pulmonary Hypertension ; Female ; Hospital Mortality ; Humans ; Hypertension, Pulmonary - diagnosis ; Hypertension, Pulmonary - etiology ; Hypertension, Pulmonary - mortality ; Hypertension, Pulmonary - physiopathology ; Hypertension, Pulmonary - therapy ; Intensive care medicine ; Japan ; Male ; Medical sciences ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Pharmacology. Drug treatments ; Pulmonary Artery - diagnostic imaging ; Pulmonary Artery - physiopathology ; Pulmonary Edema - etiology ; Pulmonary Embolism - complications ; Pulmonary Embolism - diagnosis ; Pulmonary Embolism - mortality ; Pulmonary Embolism - physiopathology ; Pulmonary Embolism - therapy ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Recovery of Function ; Reperfusion Injury - etiology ; Risk Factors ; Time Factors ; Tomography, X-Ray Computed ; Treatment Outcome ; Vascular wall</subject><ispartof>Circulation. Cardiovascular interventions, 2012-12, Vol.5 (6), p.756-762</ispartof><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-8ef0c1654a66529f44ebf7fc85ca3ba5b7444046bdb3a4be61a600b29df7b93b3</citedby><cites>FETCH-LOGICAL-c532t-8ef0c1654a66529f44ebf7fc85ca3ba5b7444046bdb3a4be61a600b29df7b93b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26818835$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23132237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KATAOKA, Masaharu</creatorcontrib><creatorcontrib>INAMI, Takumi</creatorcontrib><creatorcontrib>SATOH, Toru</creatorcontrib><creatorcontrib>HAYASHIDA, Kentaro</creatorcontrib><creatorcontrib>SHIMURA, Nobuhiko</creatorcontrib><creatorcontrib>ISHIGURO, Haruhisa</creatorcontrib><creatorcontrib>ABE, Takayuki</creatorcontrib><creatorcontrib>TAMURA, Yuichi</creatorcontrib><creatorcontrib>ANDO, Motomi</creatorcontrib><creatorcontrib>FUKUDA, Keiichi</creatorcontrib><creatorcontrib>YOSHINO, Hideaki</creatorcontrib><title>Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension</title><title>Circulation. Cardiovascular interventions</title><addtitle>Circ Cardiovasc Interv</addtitle><description>Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension.
Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P<0.01). Hemodynamic parameters also significantly improved (mean pulmonary arterial pressure, 45.3 ± 9.8 versus 31.8 ± 10.0 mm Hg; cardiac output, 3.6 ± 1.2 versus 4.6 ± 1.7 L/min, baseline versus follow-up, respectively; both P<0.01). Twenty-seven of 51 procedures in total (53%), and 19 of 28 first procedures (68%), had reperfusion pulmonary edema as the chief complication. Patients with severe clinical signs and/or severe hemodynamics at baseline had a high risk of reperfusion pulmonary edema.
PTPA improved subjective symptoms and objective variables, including pulmonary hemodynamics. PTPA may be a promising therapeutic strategy for the treatment of chronic thromboembolic pulmonary hypertension.
URL: http://www.umin.ac.jp. Unique identifier: UMIN000001572.</description><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Angioplasty, Balloon - adverse effects</subject><subject>Angioplasty, Balloon - mortality</subject><subject>Arterial Pressure</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Cardiovascular system</subject><subject>Chronic Disease</subject><subject>Diseases of the cardiovascular system</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Familial Primary Pulmonary Hypertension</subject><subject>Female</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - diagnosis</subject><subject>Hypertension, Pulmonary - etiology</subject><subject>Hypertension, Pulmonary - mortality</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Hypertension, Pulmonary - therapy</subject><subject>Intensive care medicine</subject><subject>Japan</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Artery - diagnostic imaging</subject><subject>Pulmonary Artery - physiopathology</subject><subject>Pulmonary Edema - etiology</subject><subject>Pulmonary Embolism - complications</subject><subject>Pulmonary Embolism - diagnosis</subject><subject>Pulmonary Embolism - mortality</subject><subject>Pulmonary Embolism - physiopathology</subject><subject>Pulmonary Embolism - therapy</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Recovery of Function</subject><subject>Reperfusion Injury - etiology</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><subject>Vascular wall</subject><issn>1941-7640</issn><issn>1941-7632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkF9LHDEUxYO0qLV-BZkHC76szb_JzEBfZNjWBVnFTn0dkuyNRjLJNskU9ts3Zbf6EG5y-N17Tw5ClwRfEyLIV22jtj5D_AM-2-BTkel11xDW4SN0SjpOFo1g9MPbneMT9CmlV4yLLOgxOqGMMEpZc4riA0Q9Z-khzKkaovTJzZP10lUPs5uCl3FX3fhnG7ZOpryrTIhVfoGCgsxTsVAFU_UvMXirq6HUSQUox5Xn-4Tb3RZiBp-K4c_oo5EuwfmhnqFf35dDf7u4u_-x6m_uFrpmNC9aMFgTUXMpRE07wzko0xjd1loyJWvVcM4xF2qjmOQKBJECY0W7jWlUxxQ7Q1f7udsYfs-Q8jjZpMG5_WdHQhtGG1wzXtBve1THkFIEM26jnYrxkeDxX-pjv3rsV-th-fi0XA-r-_XPItNxn3ppvzhsmtUEm7fm_zEX4MsBkElLZ0rM2qZ3TrSkbVnN_gK-n5Ls</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>KATAOKA, Masaharu</creator><creator>INAMI, Takumi</creator><creator>SATOH, Toru</creator><creator>HAYASHIDA, Kentaro</creator><creator>SHIMURA, Nobuhiko</creator><creator>ISHIGURO, Haruhisa</creator><creator>ABE, Takayuki</creator><creator>TAMURA, Yuichi</creator><creator>ANDO, Motomi</creator><creator>FUKUDA, Keiichi</creator><creator>YOSHINO, Hideaki</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension</title><author>KATAOKA, Masaharu ; INAMI, Takumi ; SATOH, Toru ; HAYASHIDA, Kentaro ; SHIMURA, Nobuhiko ; ISHIGURO, Haruhisa ; ABE, Takayuki ; TAMURA, Yuichi ; ANDO, Motomi ; FUKUDA, Keiichi ; YOSHINO, Hideaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-8ef0c1654a66529f44ebf7fc85ca3ba5b7444046bdb3a4be61a600b29df7b93b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Angioplasty, Balloon - adverse effects</topic><topic>Angioplasty, Balloon - mortality</topic><topic>Arterial Pressure</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Cardiovascular system</topic><topic>Chronic Disease</topic><topic>Diseases of the cardiovascular system</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Familial Primary Pulmonary Hypertension</topic><topic>Female</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - diagnosis</topic><topic>Hypertension, Pulmonary - etiology</topic><topic>Hypertension, Pulmonary - mortality</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Hypertension, Pulmonary - therapy</topic><topic>Intensive care medicine</topic><topic>Japan</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Artery - diagnostic imaging</topic><topic>Pulmonary Artery - physiopathology</topic><topic>Pulmonary Edema - etiology</topic><topic>Pulmonary Embolism - complications</topic><topic>Pulmonary Embolism - diagnosis</topic><topic>Pulmonary Embolism - mortality</topic><topic>Pulmonary Embolism - physiopathology</topic><topic>Pulmonary Embolism - therapy</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Recovery of Function</topic><topic>Reperfusion Injury - etiology</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><topic>Vascular wall</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KATAOKA, Masaharu</creatorcontrib><creatorcontrib>INAMI, Takumi</creatorcontrib><creatorcontrib>SATOH, Toru</creatorcontrib><creatorcontrib>HAYASHIDA, Kentaro</creatorcontrib><creatorcontrib>SHIMURA, Nobuhiko</creatorcontrib><creatorcontrib>ISHIGURO, Haruhisa</creatorcontrib><creatorcontrib>ABE, Takayuki</creatorcontrib><creatorcontrib>TAMURA, Yuichi</creatorcontrib><creatorcontrib>ANDO, Motomi</creatorcontrib><creatorcontrib>FUKUDA, Keiichi</creatorcontrib><creatorcontrib>YOSHINO, Hideaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation. Cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KATAOKA, Masaharu</au><au>INAMI, Takumi</au><au>SATOH, Toru</au><au>HAYASHIDA, Kentaro</au><au>SHIMURA, Nobuhiko</au><au>ISHIGURO, Haruhisa</au><au>ABE, Takayuki</au><au>TAMURA, Yuichi</au><au>ANDO, Motomi</au><au>FUKUDA, Keiichi</au><au>YOSHINO, Hideaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension</atitle><jtitle>Circulation. Cardiovascular interventions</jtitle><addtitle>Circ Cardiovasc Interv</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>5</volume><issue>6</issue><spage>756</spage><epage>762</epage><pages>756-762</pages><issn>1941-7640</issn><eissn>1941-7632</eissn><abstract>Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension.
Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P<0.01). Hemodynamic parameters also significantly improved (mean pulmonary arterial pressure, 45.3 ± 9.8 versus 31.8 ± 10.0 mm Hg; cardiac output, 3.6 ± 1.2 versus 4.6 ± 1.7 L/min, baseline versus follow-up, respectively; both P<0.01). Twenty-seven of 51 procedures in total (53%), and 19 of 28 first procedures (68%), had reperfusion pulmonary edema as the chief complication. Patients with severe clinical signs and/or severe hemodynamics at baseline had a high risk of reperfusion pulmonary edema.
PTPA improved subjective symptoms and objective variables, including pulmonary hemodynamics. PTPA may be a promising therapeutic strategy for the treatment of chronic thromboembolic pulmonary hypertension.
URL: http://www.umin.ac.jp. Unique identifier: UMIN000001572.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>23132237</pmid><doi>10.1161/circinterventions.112.971390</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1941-7640 |
| ispartof | Circulation. Cardiovascular interventions, 2012-12, Vol.5 (6), p.756-762 |
| issn | 1941-7640 1941-7632 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1273270534 |
| source | MEDLINE; American Heart Association; EZB-FREE-00999 freely available EZB journals |
| subjects | Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Angioplasty, Balloon - adverse effects Angioplasty, Balloon - mortality Arterial Pressure Biological and medical sciences Biomarkers - blood Cardiovascular system Chronic Disease Diseases of the cardiovascular system Emergency and intensive care: renal failure. Dialysis management Familial Primary Pulmonary Hypertension Female Hospital Mortality Humans Hypertension, Pulmonary - diagnosis Hypertension, Pulmonary - etiology Hypertension, Pulmonary - mortality Hypertension, Pulmonary - physiopathology Hypertension, Pulmonary - therapy Intensive care medicine Japan Male Medical sciences Middle Aged Natriuretic Peptide, Brain - blood Pharmacology. Drug treatments Pulmonary Artery - diagnostic imaging Pulmonary Artery - physiopathology Pulmonary Edema - etiology Pulmonary Embolism - complications Pulmonary Embolism - diagnosis Pulmonary Embolism - mortality Pulmonary Embolism - physiopathology Pulmonary Embolism - therapy Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Recovery of Function Reperfusion Injury - etiology Risk Factors Time Factors Tomography, X-Ray Computed Treatment Outcome Vascular wall |
| title | Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A56%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Percutaneous%20Transluminal%20Pulmonary%20Angioplasty%20for%20the%20Treatment%20of%20Chronic%20Thromboembolic%20Pulmonary%20Hypertension&rft.jtitle=Circulation.%20Cardiovascular%20interventions&rft.au=KATAOKA,%20Masaharu&rft.date=2012-12-01&rft.volume=5&rft.issue=6&rft.spage=756&rft.epage=762&rft.pages=756-762&rft.issn=1941-7640&rft.eissn=1941-7632&rft_id=info:doi/10.1161/circinterventions.112.971390&rft_dat=%3Cproquest_cross%3E1273270534%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1273270534&rft_id=info:pmid/23132237&rfr_iscdi=true |